As of 8 Nov 2026, Octopath AI has raised $2.0M across 1 verified round on record (amounts in other currencies converted to USD); latest: £1.5M seed round led by Twinpath, announced 2 Nov 2026.
Advanced AI models for analyzing tissue slides at the single-cell level, specifically targeting oncology.
octopath.aiLondon, UKHealthtechFounded 2026
3 sources · checked 3 times, last 29m ago
The £1.5million figure combines seed investment and grant funding. UCL states that the £500,000 grant was matched by the seed round but does not state the seed-only amount.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed | $2.0M £1.5M | 2026-11-02 | Twinpath | 3 outlets. #31 in Trending |
3 sources · checked 3 times, last 29m ago [ VERIFIED · CORRECTED ] read against 3 sources
The £1.5million figure combines seed investment and grant funding. UCL states that the £500,000 grant was matched by the seed round but does not state the seed-only amount. | ||||
Octopath AI builds AI tools that count, classify and score cells on digital pathology slides for pathologists, hospitals, researchers and pharmaceutical and biotech trial teams.
Checked against 8 sources yesterday
Also named as backers in company research: Innovate UK